Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List

Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab

Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab

HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific...

Snail Games USA Set to Attract New Players and Showcase Updates During 2025 Steam Autumn Sale

Snail Games USA Set to Attract New Players and Showcase Updates During 2025 Steam Autumn Sale

CULVER CITY, Calif., Nov. 27, 2024 /PRNewswire/ -- Snail, Inc. (Nasdaq: SNAL) ("Snail Games" or the "Company"), a leading global independent developer and publisher of interactive digital entertainment, is excited to announce its participation in...

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI, Nov. 27, 2024...

"The Summer Hikaru Died" Anime is Coming Soon to Netflix

"The Summer Hikaru Died" Anime is Coming Soon to Netflix

Reveals New Teaser Visual, Trailer, Cast & Staff TOKYO, Nov. 27, 2024 /PRNewswire/ -- CyberAgent, Inc. (Head office: Shibuya-ku, Tokyo; President: Susumu Fujita; TSE: 4751) today announced the television anime of up-and-coming award winning...

Everest Group Names SS&C Blue Prism a Leader in Process Orchestration Products PEAK Matrix® 2024

Everest Group Names SS&C Blue Prism a Leader in Process Orchestration Products PEAK Matrix® 2024

WINDSOR, Conn., Nov. 26, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a process orchestration Leader in the Everest Group Process Orchestration Products PEAK Matrix®...

QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology

QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology

SINGAPORE, Nov. 26, 2024 /PRNewswire/ -- QDX proudly announces that the team led by its co-founder, Associate Professor Giuseppe Barca, has been honoured with the 2024 ACM Gordon Bell Prize, often referred to as the "Nobel Prize of high-performance...

TRACCOM INC. (Pink Open Market Symbol: TRCC) COMPLETES ACQUISITION OF VULCAIN, INC.

TRACCOM INC. (Pink Open Market Symbol: TRCC) COMPLETES ACQUISITION OF VULCAIN, INC.

SANTA BARBARA, Calif., Nov. 26, 2024 /PRNewswire/ -- Traccom Inc. (Pink Open Market Symbol: TRCC) is pleased to announce that on November 13, 2024, it acquired all of the capital stock of Vulcain, Inc. ("Vulcain"). As a result of the acquisition,...

FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. Announce Strategic Partnership

FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. Announce Strategic Partnership

MOMENCE, Ill., Nov. 25, 2024 /PRNewswire/ -- FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. announced today a strategic global sales and manufacturing partnership to expand FutureCeuticals' portfolio of clinically proven dietary supplement...

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

ROCKVILLE, Md. and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...

  • 1
  • ...
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • ...
  • 14
  • menu
    menu